跳至主要内容
临床试验/NCT01369810
NCT01369810已完成不适用

Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or COPD in Iceland

AstraZeneca1 个研究点 分布在 1 个国家目标入组 20,000 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
20,000
试验地点
1
主要终点
To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

研究概览

简要总结

To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010

排除标准

  • 未提供

结局指标

主要结局

To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

时间窗: Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years

次要结局

  • To map out the development of asthma and COPD treatment in Iceland after the change in reimbursement(Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years)
  • To investigate health economic outcomes(Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验